全文获取类型
收费全文 | 6015篇 |
免费 | 245篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 193篇 |
儿科学 | 316篇 |
妇产科学 | 249篇 |
基础医学 | 407篇 |
口腔科学 | 307篇 |
临床医学 | 591篇 |
内科学 | 1422篇 |
皮肤病学 | 82篇 |
神经病学 | 364篇 |
特种医学 | 234篇 |
外科学 | 1252篇 |
综合类 | 97篇 |
预防医学 | 138篇 |
眼科学 | 239篇 |
药学 | 216篇 |
中国医学 | 6篇 |
肿瘤学 | 198篇 |
出版年
2024年 | 4篇 |
2023年 | 56篇 |
2022年 | 72篇 |
2021年 | 128篇 |
2020年 | 96篇 |
2019年 | 139篇 |
2018年 | 155篇 |
2017年 | 132篇 |
2016年 | 167篇 |
2015年 | 205篇 |
2014年 | 223篇 |
2013年 | 299篇 |
2012年 | 426篇 |
2011年 | 395篇 |
2010年 | 238篇 |
2009年 | 213篇 |
2008年 | 483篇 |
2007年 | 528篇 |
2006年 | 506篇 |
2005年 | 450篇 |
2004年 | 365篇 |
2003年 | 297篇 |
2002年 | 242篇 |
2001年 | 120篇 |
2000年 | 109篇 |
1999年 | 103篇 |
1998年 | 30篇 |
1997年 | 26篇 |
1996年 | 19篇 |
1995年 | 9篇 |
1994年 | 10篇 |
1993年 | 10篇 |
1992年 | 12篇 |
1991年 | 17篇 |
1990年 | 8篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1971年 | 3篇 |
1970年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有6311条查询结果,搜索用时 31 毫秒
1.
2.
3.
Targeting in a cellular level is still one of the major challenges in biomedical treatments. However, new synthetic and analytical techniques now allow the development of precisely prepared macromolecules. Thus, glycopolymer chains are reported to be prepared with controlled length, monomer sequences, as well as chain‐folded structures. A high level of complexity in synthetic macromolecules also allows increased selectivity in targeting, which is a key factor in biomedical applications. 相似文献
4.
5.
Formulation and in Vitro-in Vivo Evaluation of Sustained-Release Lithium Carbonate Tablets 总被引:1,自引:0,他引:1
Çiftçi Kadriye Çapan Yilmaz Öztürk Orhan Hincal A. Atilla 《Pharmaceutical research》1990,7(4):359-363
The release of lithium carbonate incorporated into polymethylmethacrylate, poly vinyl chloride, hy-drogenated vegetable oil, and carbomer matrix tablets was studied in vitro. The formulation containing 10% carbomer showed a sustained-release profile comparable to that of a standard, commercially available, sustained-release preparation containing 400 mg lithium carbonate embedded in a composite material. In vivo the newly formulated and standard sustained-release lithium carbonate tablets were compared to an oral solution and conventional lithium carbonate tablets in 12 healthy subjects. These crossover studies showed that the sustained-release tablets produced a flatter serum concentration curve than the oral solution and conventional tablet, without loss of total bioavailability. 相似文献
6.
7.
8.
Z Yilmaz T Renton Y Yiangou J Zakrzewska I P Chessell C Bountra P Anand 《Journal of clinical neuroscience》2007,14(9):864-871
Burning mouth syndrome (BMS) is often an idiopathic chronic and intractable pain condition, affecting 1.5-5.5% of middle-aged and elderly women. We have studied the heat and capsaicin receptor TRPV1, and its regulator nerve growth factor (NGF), in BMS. Patients with BMS (n=10) and controls (n=10) were assessed for baseline and post-topical capsaicin pain scores, and their tongue biopsies immunostained for TRPV1, NGF, and structural nerve markers neurofilament and peripherin. Nerve fibres penetrating the epithelium were less abundant in BMS (p<0.0001), indicating a small fibre neuropathy. TRPV1-positive fibres were overall significantly increased in BMS (p=0.0011), as were NGF fibres (p<0.0001) and basal epithelial cell NGF staining (p<0.0147). There was a significant correlation between the baseline pain score and TRPV1 (p=0.0143) and NGF fibres (p=0.0252). A significant correlation was observed between baseline and post-capsaicin pain (p=0.0006). Selective TRPV1 and NGF blockers may provide a new therapy for BMS. 相似文献
9.
Monoclonal Antibody Specific for TIRC7 Induces Donor-specific Anergy and Prevents Rejection of Cardiac Allografts in Mice 总被引:1,自引:0,他引:1
Yusuke Kumamoto Antje Tomschegg Fatima Bennai-Sanfourche Anke Boerner Arthur Kaser Isabella Schmidt-Knosalla Thomas Heinemann Mirko Schlawinsky Richard S. Blumberg Hans-Dieter Volk Nalan Utku 《American journal of transplantation》2004,4(4):505-514
T cell immune response c-DNA (TIRC7) is up-regulated during the early stages of T-cell activation in response to alloantigens. In this study, we analyzed the effects of newly developed monoclonal antibodies (mAb) against TIRC7 in acute cardiac allograft rejection. Fully vascularized heterotopic allogeneic heart transplantation was performed in mice across a full-mismatch barrier (C57Bl/10 into CBA). Recipients received seven injections (day 0-7) of a novel anti-TIRC7 mAb or remained untreated. Graft survival, histology and ex vivo lymphocyte functions were tested. Targeting of TIRC7 with an anti-TIRC7 mAb diminishes lymphocyte infiltration into grafts resulting in delay of morphological graft damage and prolongation of allograft survival. The lymphocytes from anti-TIRC7 mAb-treated animals exhibit hypo-responsiveness without evidence of lymphocyte depletion against the donor allo-antigens. Proliferation and expression of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) were down-regulated while interleukin-4 (IL-4) and IL-10 expression were spared. Moreover, anti-TIRC7 mAb enhanced up-regulation of CTLA-4 expression but suppressed up-regulation of CD25 on stimulated lymphocytes in vitro and in vivo. Ligation of TIRC7 has important effects on the regulation of co-stimulatory signaling pathways associated with suppressing of T-cell activation. Targeting of TIRC7 may therefore provide a novel therapeutic approach for modulating T cell immune responses during organ transplantation. 相似文献
10.